Farther Finance Advisors, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1992825 SAN FRANCISCO, CA

Position in TEVA

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$335,898

+$33,661 QoQ

Shares Held

11,152

+15.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $5,648,119 across 52 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	11,645	$1,376,555
2	VTRS	Viatris Inc	43,117	$582,510
3	UTHR	UNITED THERAPEUTICS Corp	818	$485,057
4	HIMS	Hims & Hers Health, Inc.	20,825	$432,327
5	NBIX	Neurocrine Biosciences Inc	2,947	$388,237
6	COLL	Collegium Pharmaceutical, Inc	11,677	$386,158
7	TEVA	Teva Pharmaceutical Industries Ltd This page	11,152	$335,898
8	TAK	Takeda Pharmaceutical Co Ltd	17,828	$330,174

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$335,898	11,152	+15.2%	Shares	Sole	2026-04-07
2025-12-31	$302,237	9,684	+31.4%	Shares	Sole	2026-01-23
2025-09-30	$148,894	7,371	+11.3%	Shares	Sole	2025-10-14
2025-06-30	$110,984	6,622	-1.8%	Shares	Sole	2025-07-11
2025-03-31	$103,593	6,740	+2.2%	Shares	Sole	2025-04-14
2024-12-31	$145,287	6,592	+45.3%	Shares	Sole	2025-02-10
2024-09-30	$81,774	4,538	+273.5%	Shares	Sole	2024-10-29
2024-06-30	$19,743	1,215	-11.6%	Shares	Sole	2024-07-31
2024-03-31	$19,401	1,375	+0.7%	Shares	Sole	2024-05-14
2023-12-31	$14,261	1,366	+239.0%	Shares	Sole	2024-02-15
2023-09-30	$4,110	403	+14.8%	Shares	Sole	2023-11-14
2023-06-30	$2,643	351	+80.0%	Shares	Sole	2024-05-14
2023-03-31	$1,725	195	0.0%	Shares	Sole	2024-05-14
2022-12-31	$1,778	195	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.